FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
Rob Schroeder, Washington Bureau Chief at MarketWatch, breaks down Democrats' midterm sweep, Wall Street's reaction and what's next for Trump's economy.
Custom Truck One Source CEO Ryan McMonagle explains how AI data centers and power grid upgrades are fueling equipment demand as rental revenue jumps 20% higher.